National Instruments (NASDAQ:NATI) fell almost 1% amid a report that it filed for a standard review in China for its planned sale to Emerson (NYSE:EMR). The $8.2 billion sale to Emerson (EMR) was ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果